Correlation Between Inovio Pharmaceuticals and Regenicin
Can any of the company-specific risk be diversified away by investing in both Inovio Pharmaceuticals and Regenicin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inovio Pharmaceuticals and Regenicin into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inovio Pharmaceuticals and Regenicin, you can compare the effects of market volatilities on Inovio Pharmaceuticals and Regenicin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inovio Pharmaceuticals with a short position of Regenicin. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inovio Pharmaceuticals and Regenicin.
Diversification Opportunities for Inovio Pharmaceuticals and Regenicin
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Inovio and Regenicin is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Inovio Pharmaceuticals and Regenicin in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regenicin and Inovio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inovio Pharmaceuticals are associated (or correlated) with Regenicin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regenicin has no effect on the direction of Inovio Pharmaceuticals i.e., Inovio Pharmaceuticals and Regenicin go up and down completely randomly.
Pair Corralation between Inovio Pharmaceuticals and Regenicin
If you would invest 0.01 in Regenicin on September 2, 2024 and sell it today you would earn a total of 0.00 from holding Regenicin or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inovio Pharmaceuticals vs. Regenicin
Performance |
| Timeline |
| Inovio Pharmaceuticals |
| Regenicin |
Inovio Pharmaceuticals and Regenicin Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inovio Pharmaceuticals and Regenicin
The main advantage of trading using opposite Inovio Pharmaceuticals and Regenicin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inovio Pharmaceuticals position performs unexpectedly, Regenicin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regenicin will offset losses from the drop in Regenicin's long position.| Inovio Pharmaceuticals vs. Novavax | Inovio Pharmaceuticals vs. Vaxart Inc | Inovio Pharmaceuticals vs. Enveric Biosciences | Inovio Pharmaceuticals vs. Ocean Biomedical |
| Regenicin vs. Denali Therapeutics | Regenicin vs. Cardiff Oncology | Regenicin vs. Cytodyn | Regenicin vs. Inovio Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |